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Abstracta
Introduction: Noninvasive continuous positive airway pressure (CPAP) is recognized as an effective treatment for
severe airway obstruction in young children. The aim of the present study was to compare a clinical setting with a
physiological setting of noninvasive CPAP in infants with nocturnal alveolar hypoventilation due to severe upper
airway obstruction (UAO) or bronchopulmonary dysplasia (BPD).
Methods: The breathing pattern and respiratory muscle output of all consecutive infants due to start CPAP in our
noninvasive ventilation unit were retrospectively analysed. CPAP set on clinical noninvasive parameters (clinical
CPAP) was compared to CPAP set on the normalization or the maximal reduction of the oesophageal pressure
(Poes) and transdiaphragmatic pressure (Pdi) swings (physiological CPAP). Expiratory gastric pressure (Pgas) swing
was measured.
Results: The data of 12 infants (mean age 10 ± 8 mo) with UAO (n = 7) or BPD (n = 5) were gathered. The mean
clinical CPAP (8 ± 2 cmH2O) was associated with a significant decrease in Poes and Pdi swings. Indeed, Poes swing
decreased from 31 ± 15 cmH2O during spontaneous breathing to 21 ± 10 cmH2O during CPAP (P < 0.05). The
mean physiological CPAP level was 2 ± 2 cmH2O higher than the mean clinical CPAP level and was associated
with a significantly greater improvement in all indices of respiratory effort (Poes swing 11 ± 5 cm H2O; P < 0.05
compared to clinical CPAP). Expiratory abdominal activity was present during the clinical CPAP and decreased
during physiological CPAP.
Conclusions: A physiological setting of noninvasive CPAP, based on the recording of Poes and Pgas, is superior to
a clinical setting, based on clinical noninvasive parameters. Expiratory abdominal activity was present during
spontaneous breathing and decreased in the physiological CPAP setting.
Keywords: Airway obstruction, Continuous positive airway pressure, Oesophageal pressure, Expiratory abdominal
activity, Infant
Introduction
Noninvasive continuous positive airway pressure (CPAP) is
recognized as an effective treatment for severe upper
airway obstruction (UAO) in young children. Indeed, the
maintenance of airway patency throughout the entire
breathing cycle by means of CPAP has been shown to be
associated with an unloading of the respiratory muscles, an
improvement of breathing pattern and gas exchange [1-6].
In adults and adolescents with obstructive sleep apnoea
(OSA), the titration of CPAP is based on the polysomno-
graphic disappearance of apnoea, hypopnoea, respiratory
effort-related arousal and snoring, as recommended by
the American Academy of Sleep Medicine (AASM) [7,8].
The diseases responsible for airway obstruction in
infants differ from those of older children and adults with
the predominance of anatomical abnormalities of the
upper airways such as laryngomalacia or tracheomalacia,
* Correspondence: brigitte.fauroux@trs.aphp.fr
2AP-HP, Hôpital Armand Trousseau, Pediatric Pulmonary Department, Paris,
France
Full list of author information is available at the end of the article
Khirani et al. Critical Care 2013, 17:R167
http://ccforum.com/content/17/4/R167
© 2013 Fauroux et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Pierre Robin syndrome or other maxillofacial malfor-
mations [3,6].
Some other diseases involving the lower respiratory
tract, such as chronic lung diseases of prematurity, also
called bronchopulmonary dysplasia (BPD), are associated
with lung diseases and predominantly peripheral airway
obstruction, which may be severe and cause intrinsic
positive end-expiratory pressure (PEEPi). Because of
these differences in pathophysiology and the lack of
guidelines for this age group, the titration of CPAP in
infants is generally based on clinical parameters such as
the disappearance of the stridor and retractions, the
decrease in respiratory and heart rates and the normali-
zation of gas exchange [2,3]. To facilitate the acclimati-
zation of the infant with CPAP, the initial level is
usually set at 4 cmH2O, followed by a gradual increase
of the CPAP level until the best clinical efficacy and
comfort are obtained.
Importantly, small changes in the CPAP level may have
significant clinical consequences. Indeed, the minimal
airway diameter is the most critical because, according to
Poiseuille’s law, the resistance increases with an exponent
4 of the radius. This has been observed in infants with
acute viral bronchiolitis, in whom a 2 cmH2O change of
CPAP level was associated with a significant change in
the work of breathing and breathing pattern [9]. In such
a homogeneous group of infants, the optimal CPAP level,
determined by monitoring the oesophageal (Poes) and
gastric pressure (Pgas), was 7 cmH2O for all the patients;
however, it is not known if this level is also appropriate
for infants with UAO and BPD, in whom CPAP could
counteract the PEEPi.
The aim of the present study was to compare two set-
tings of CPAP: a first setting based on noninvasive clini-
cal parameters and a second setting based on the invasive
recording of Poes and Pgas in a group of infants with
severe UAO or BPD.
Materials and methods
Patients
All the data of consecutive infants less than 24 months
old with severe UAO or BPD evaluated for noninvasive
CPAP in a noninvasive ventilation unit of a paediatric
university hospital were retrospectively analysed. All the
patients with UAO had a laryngotracheal endoscopy
under general anaesthesia. The UAO persisted in all the
UAO patients despite endoscopic resection of the arye-
piglottic folds and antireflux treatment using proton
pump inhibitors. All the UAO and BPD patients were
hypoxaemic (pulse oximetry (SpO2) less than 90% for
more than 10 consecutive min and/or more than 10% of
sleep time) and hypercapnic (transcutaneous carbon diox-
ide pressure (PtcCO2) above 50 mmHg for more than 10
consecutive min and/or more than 10% of sleep time)
during an overnight sleep study [6]. Exclusion criteria
were severe mental retardation and important midfacial
deformity precluding the tolerance of a nasal mask. The
study was approved by the Institutional Review Board of
the French learned society for respiratory medicine,
Société de Pneumologie de Langue Française (CEPRO
2012-031), and all the parents gave informed consent for
the CPAP evaluation of their children.
CPAP equipment
Because of the lack of adequate nasal interfaces for
infants, all the patients were equipped with custom-made
nasal masks manufactured by the prosthetists of the max-
illofacial department of our hospital [10,11]. The CPAP
devices used for the study were the Synchrony or
Harmony (Philips Respironics, Murrysville, PA, USA), S9
or VPAP IV (ResMed, Bella Vista, Australia) and ICON
(Fisher & Paykel Healthcare, Auckland, NZ) with an inte-
grated humidification system. A commercial simple line
circuit, recommended by the manufacturer, was con-
nected to the nasal mask via an exhalation valve (Plateau
Exhalation Valve; Philips Respironics). Oxygen therapy
was not used during the study.
Measurements
Airway pressure (Paw) was measured with a differential
pressure transducer (MP45 Low Pressure Transducer
model ± 100 cmH2O; Validyne Engineering Corp, North-
ridge, CA, USA) on the Plateau Exhalation Valve during
CPAP treatment. We were not able to measure airflow
during spontaneous breathing, because the infants did
not tolerate the mask alone with the pneumotachograph
due to the increase in dead space and during CPAP
because of the constant airflow.
Poes and Pgas were measured using a 2.1-mm external
diameter catheter mounted pressure transducer system
with two integrated pressure transducers (Gaeltec, Dunve-
gan, Isle of Skye, UK) inserted pernasally after careful local
anaesthesia (lidocaine 2%; AstraZeneca, Rueil-Malmaison,
France) [12,13]. After calibration, the catheter was
advanced gently until the distal tip was in the stomach
and the proximal pressure transducer was in the middle
portion of the oesophagus. Appropriate placement of the
Poes transducer was assessed using the occlusion techni-
que [14]. Adequate placement of the Pgas transducer was
ascertained by gentle manual pressure on the patient’s
abdomen to observe fluctuations in Pgas, which should be
absent on the Poes trace. Transdiaphragmatic pressure
(Pdi) was obtained by online subtracting of the Poes signal
from the Pgas signal. All the signals were digitized at 128
Hz and sampled for analysis using an analogical/numeric
acquisition system (MP100 System; BIOPAC Systems, Inc,
Goleta, CA, USA), run on a PC computer (Elonex, Genne-
villiers, France) and displayed using AcqKnowledge
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software (BIOPAC Systems, Inc). SpO2, heart rate and
respiratory rate (fR) were recorded.
Protocol
No sedation was administered. The procedure was per-
formed with the presence of at least one parent (generally
the mother) and started with the placement of the oeso-
gastric catheter at the time of a natural daytime nap. After
10 min of quiet breathing (ideally sleep), a 2-min baseline
recording (spontaneous breathing) was taken. Next, the
oesogastric recording was blinded to the investigator, and
CPAP was started with an initial CPAP level at 4 cmH2O
followed by a 1 cmH2O increase every 5 min until maxi-
mal clinical improvement. The clinical CPAP level con-
sidered optimal was the level associated with the
disappearance of the stridor or retractions, a SpO2 greater
than 95% on room air, the normalization or greatest
decrease in heart rate and fR and the best comfort as
assessed by the infant’s remaining or falling asleep. After
10 min of quiet breathing at this CPAP level, a 2-min
recording (clinical CPAP) was performed. Thereafter the
CPAP level was decreased to the baseline value of
4 cmH2O for 5 min. After this period, the oesogastric
recording was revealed to the investigator. The CPAP level
was then adjusted on the normalization or the maximal
decrease in the Poes swing, independently of the clinical
parameters. After 10 min of quiet breathing at this CPAP
level, a 2-min recording (physiological CPAP) was per-
formed. Next, the CPAP level was increased by 1 cmH2O.
A 2-min recording (physiological CPAP+1) was performed
after 10 min of quiet breathing. The long-term CPAP use
and clinical outcome were assessed in all patients.
Data analysis
fR and inspiratory time/total respiratory cycle time (TI/
TTOT) ratio were estimated from the Poes trace. Poes and
Pdi swings and the oesophageal pressure time product
(PTPoes) and diaphragmatic pressure-time product
(PTPdi) per breath and per minute were measured and
calculated as previously described [12,15-17]. Normally,
PTPoes is measured as the area subtended by Poes and
the chest wall static recoil pressure-time curve over the
TI, taking into account the PEEPi, as described by Sas-
soon et al. [15]. As it was impossible to measure airflow
in these infants, owing to the increase in dead space
when a face mask was added or during CPAP because of
the continuous positive airflow, we could not measure
the real TI. For the calculation of the PTPoes/breath, the
onset of inspiration was thus defined as the deflection on
the Poes trace and the end of the inspiration as the peak
of Pdi [18]. The PTPdi/breath was obtained by measuring
the area under the Pdi signal from the onset of its posi-
tive deflection to its return to baseline. Both PTPoes and
PTPdi were also expressed per minute by multiplying the
pressure-time products per breath by the fR (PTPoes/min
and PTPdi/min) [15]. The Pgas swing during expiration
was measured as a marker of expiratory abdominal activity.
On the Pgas trace, we measured the decrease from the
maximal end-expiratory level to the minimal value [19].
The presence of a positive Pgas swing during expiration
was considered abnormal [20].
Statistical analysis
Data are given as means ± SD. Comparisons between the
baseline and different CPAP conditions were made using
(1) one-way or one-factor repeated-measures analysis of
variance (ANOVA) if data were normally distributed or
(2) Friedman repeated-measures ANOVA on ranks if data
were not normally distributed. When a significant differ-
ence was observed, pairwise comparisons were performed
using the Holm-Sidak test. The CPAP levels were com-
pared using a t-test if data were normally distributed or a
Mann-Whitney U test if data were not normally distribu-
ted. A P value less than 0.05 was considered statistically
significant.
Results
Twelve infants (mean post natal age 10 ± 8 mo, mean
weight 6.6 ± 2.3 kg) were enrolled in the study (Table 1).
Seven infants had severe UAO, and five infants had BPD.
Spontaneous breathing pattern showed high values of fR,
TI/TTOT ratio and respiratory effort, as shown by the
increase in the Poes and Pgas swings, PTPoes/breath and
PTPdi/breath, and PTPoes/min and PTPdi/min (Tables 2
and 3 and Figures 1 and 2). The mean fR tended to be
slightly higher for the BPD patients (54 ± 6 breaths/min)
than in the UAO patients (51 ± 12 breaths/min; P =
0.612) and their TI/TTOT ratio was significantly lower
(0.4 ± 0.1 vs 0.6 ± 0.1 for the UAO patients; P = 0.003).
All the markers of respiratory effort, except the Pgas swing






1 Girl 2 3.6 Pierre Robin syndrome
2 Boy 2 5.0 Prader-Willi syndrome
3 Girl 10 6.7 Obstructive sleep apnoea
4 Boy 2 4.5 Laryngomalacia and Down
syndrome
5 Boy 3 5.1 Laryngomalacia
6 Boy 4 5.2 Laryngomalacia
7 Girl 13 9.0 Laryngomalacia
8 Boy 5 4.4 Bronchopulmonary dysplasia
9 Boy 14 8.3 Bronchopulmonary dysplasia
10 Girl 20 8.5 Bronchopulmonary dysplasia
11 Boy 22 9.0 Bronchopulmonary dysplasia
12 Boy 22 10.3 Bronchopulmonary dysplasia
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during expiration (7 ± 4 vs 1 ± 2 for the UAO patients; P
= 0.03), were statistically comparable.
The mean clinical CPAP level was 8 ± 2 cmH2O (range,
6 to 10 cmH2O) (Figure 3). This level was associated with
a significant decrease in Poes and Pdi swings (Table 2). Of
note, the mean clinical CPAP level was significantly higher
for the UAO patients (9 ± 1 cmH2O) than for the BPD
patients (7 ± 1 cmH2O) (P = 0.006) (Table 3).
The mean physiological CPAP level was 2 ± 2 cmH2O
higher than the mean clinical CPAP level and was asso-
ciated with a significantly greater improvement in fR, TI/
TTOT ratio and all the indices of respiratory effort as com-
pared to spontaneous breathing (Table 2). Interestingly,
the mean physiological CPAP level was not significantly
different between the two groups (with a mean level of
CPAP of 11 ± 2 cmH2O and 9 ± 1 cmH2O for the UAO
and BPD patients, respectively; P = 0.12). The physiologi-
cal CPAP+1 was associated with a nonsignificant increase
in the Poes swing and the PTPoes/min, together with agi-
tation and arousals in all the patients.
During spontaneous breathing, one of the five UAO
patients and all four BPD patients had a Pgas swing dur-
ing expiration (Pgas was not available for three patients
due to technical reasons) (Figure 4). During the clinical
CPAP setting, three of the seven UAO patients and all
five BPD patients had a Pgas swing during expiration.
During the physiological CPAP setting, this expiratory
abdominal activity disappeared in one of the five BPD
patients but persisted or increased in two UAO patients
(Figure 4). During the physiological CPAP+1 setting, the
expiratory abdominal activity increased in these two
UAO patients, slightly reappeared in two other UAO
patients and increased moderately in the two BPD
patients (Pgas was not available in the other three BPD
patients).
The physiological CPAP level was chosen for the
patients. The clinical tolerance of this level was excellent,
with all patients sleeping more than 6 h per night with
CPAP and the normalization of nocturnal gas exchange,
defined by a minimal SpO2 greater than 95% and a maxi-
mal PtcCO2 less than 50 mmHg. All the patients were
successfully discharged to home on long-term nasal
CPAP, and all were weaned from CPAP after a median
period of 10 mo (range, 6 mo to 3 yr). CPAP was asso-
ciated with an improvement in weight in all the patients.
Three patients could be weaned from nasogastric nutri-
tional support after 1 to 2 mo, and, in the other nine
patients, CPAP was associated with an at least 1 SD
weight gain after 1 to 3 mo. None of the patients required
a tracheotomy, and no deaths occurred.
Discussion
This study shows that a CPAP setting based on clinical
noninvasive parameters is associated with an improvement
in breathing pattern and respiratory effort in infants with
severe UAO or BPD, but this improvement is significantly
greater with an invasive physiological setting based on the
monitoring of Poes and Pgas tracings.
We evaluated two groups of patients. The first group
had severe UAO, in whom noninvasive CPAP has proven
to be efficacious [3,6]. The second group comprised
patients with severe BPD. We acknowledge that noninva-
sive CPAP is not a classic treatment for these infants, but
the patients evaluated for CPAP in the present study
Table 2 Breathing pattern, respiratory muscle output and continuous positive airway pressure level during
spontaneous breathing at clinical and two physiological settings of continuous positive airway pressure in the total
population.a
Spontaneous breathing Clinical CPAP Physiological CPAP Physiological CPAP+1 cmH2O
Respiratory parameters
fR (breaths/min) 49 ± 14 44 ± 21 38 ± 16
b 36 ± 18
TI/TTOT 0.5 ± 0.1 0.4 ± 0.1 0.4 ± 0.1
c 0.4 ± 0.1
Respiratory muscle output
Poes swing (cmH2O) 31 ± 15 21 ± 10
d 11 ± 5b 14 ± 6
Pdi swing (cmH2O) 26 ± 8 20 ± 8
d 12 ± 6b 15 ± 7
Pgas swing (cmH2O) 4 ± 2 3 ± 1 2 ± 1
c 2 ± 1
Expiratory Pgas swing (cmH2O) 4 ± 4 3 ± 5 1 ± 1 2 ± 2
PTPoes/breath (cmH2O/s) 12 ± 6 9 ± 6 6 ± 5
b 9 ± 9
PTPdi/breath (cmH2O/s) 11 ± 4 9 ± 6 6 ± 4
b 8 ± 6
PTPoes/min (cmH2O/s/min) 571 ± 340 359 ± 227 183 ± 119
e 244 ± 161
PTPdi/min (cmH2O/s/min) 452 ± 146 350 ± 164 201 ± 108
b 239 ± 173
CPAP level (cmH2O) NA 8 ± 2 10 ± 2 11 ± 2
aCPAP: continuous positive airway pressure, fR: respiratory rate, NA: not applicable, Poes: oesophageal pressure, Pdi: transdiaphragmatic pressure, Pgas: gastric
pressure, PTP: pressure-time product, TI/TTOT: inspiratory time/total respiratory cycle time ratio. bP < 0.05 between physiological CPAP and spontaneous breathing
or clinical CPAP. cP < 0.05 between spontaneous breathing and physiological CPAP. dP < 0.05 between spontaneous breathing and clinical CPAP. eP < 0.05
between physiological CPAP and spontaneous breathing, physiological CPAP or physiological CPAP+1 cmH2O.
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represent a highly selected group of patients with extre-
mely severe lung disease [21,22], as documented by the
tremendous increase in work of breathing and alveolar
hypoventilation. These patients are expected to have a
combination of lower airway obstruction and parenchy-
mal lung disease. The lower airway obstruction causes
hyperinflation and PEEPi, which is effectively counter-
acted by CPAP, unloading the respiratory muscles and
improving breathing pattern and gas exchange [23].
Despite an older age, the mean fR tended to be higher
and the mean TI/TTOT ratio lower in the BPD patients
than in the UAO patients, which may be explained by the
predominantly lower airway obstruction in BPD patients.
This may also explain the high prevalence of abnormal
expiratory abdominal activity during spontaneous breath-
ing in BPD patients.
The mean difference between the clinical CPAP and
physiological CPAP levels was 2 ± 2 cmH2O. A 1 cmH2O
increase in this physiological CPAP level was not toler-
ated by the infants with clinical arousal and an increase
in expiratory abdominal effort, as assessed on the Pgas
tracing. This narrow therapeutic CPAP range is similar
to our findings in infants hospitalized for acute viral
bronchiolitis [9]. These observations underline the sensi-
tivity of these infants to small changes in the CPAP level.
Our findings regarding the expiratory Pgas recording
are particularly interesting. Expiratory abdominal activity
can be due to hyperinflation induced by CPAP overtitra-
tion, as shown by studies in healthy awake subjects in
whom high levels of CPAP induced an expiratory
abdominal activity [24-26]. In our group of patients,
however, our hypothesis is that this expiratory abdom-
inal activity was the consequence of persistent airway
obstruction during spontaneous breathing and CPAP.
Indeed, four of nine of our patients had expiratory
abdominal activity during spontaneous breathing, which
Table 3 Breathing pattern, respiratory muscle output and continuous positive airway pressure level during
spontaneous breathing at clinical and two physiological settings of continuous positive airway pressure for the upper
airway obstruction and bronchopulmonary dysplasia patients.a
UAO (n = 7) Spontaneous breathing Clinical CPAP Physiological CPAP Physiological CPAP+1 cmH2O
Respiratory parameters
fR (breaths/min) 46 ± 16
b 36 ± 19 34 ± 17 32 ± 20
TI/TTOT 0.6 ± 0.1
b 0.5 ± 0.1 0.4 ± 0.1 0.4 ± 0.1
Respiratory muscle output
Poes swing (cmH2O) 30 ± 17
b 18 ± 10 12 ± 6 16 ± 7
Pdi swing (cmH2O) 25 ± 9
b 20 ± 10c 14 ± 7 17 ± 8
Pgas swing (cmH2O) 5 ± 2
b 3 ± 1 3 ± 1 3 ± 1
Expiratory Pgas swing (cmH2O) 1 ± 2 1 ± 1 1 ± 1 2 ± 2
PTPoes/breath (cmH2O/s) 13 ± 7 10 ± 8 7 ± 6 11 ± 10
PTPdi/breath (cmH2O/s) 12 ± 5 11 ± 7 7 ± 5 10 ± 7
PTPoes/min (cmH2O/s/min) 599 ± 415
b 291 ± 162 201 ± 150 271 ± 188
PTPdi/min (cmH2O/s/min) 459 ± 155
b 332 ± 161c 212 ± 135 262 ± 193
CPAP level (cmH2O) NA 9 ± 1 11 ± 2 12 ± 2
BPD (n = 5) Spontaneous Breathing Clinical CPAP Physiological CPAP Physiological CPAP+1 cmH2O
Respiratory parameters
fR (breaths/min) 54 ± 6 56 ± 18 45 ± 13 46 ± 11
TI/TTOT 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.1 0.4 ± 0.1
Respiratory muscle output
Poes swing (cmH2O) 32 ± 11
d 25 ± 11c 10 ± 2 11 ± 2
Pdi swing (cmH2O) 27 ± 9
d 20 ± 5c 11 ± 4 11 ± 1
Pgas swing (cmH2O) 2 ± 1 2 ± 1 2 ± 1 2 ± 0
Expiratory Pgas swing (cmH2O) 7 ± 4 7 ± 6 1 ± 1 1 ± 1
PTPoes/breath (cmH2O/s) 10 ± 4
d 9 ± 4c 4 ± 2 4 ± 2
PTPdi/breath (cmH2O/s) 9 ± 4 7 ± 3 5 ± 2 3 ± 0
PTPoes/min (cmH2O/s/min) 526 ± 201
d 468 ± 290c 156 ± 43 181 ± 43
PTPdi/min (cmH2O/s/min) 442 ± 153 379 ± 183 183 ± 50 156 ± 0
CPAP level (cmH2O) NA 7 ± 1 9 ± 1 10 ± 1
aBPD: bronchopulmonary dysplasia, CPAP: continuous positive airway pressure, fR: respiratory rate, NA: not applicable, Poes: oesophageal pressure, Pdi:
transdiaphragmatic pressure, Pgas: gastric pressure, PTP: pressure time product, TI/TTOT: inspiratory time/total respiratory cycle time ratio, UAO: upper airway
obstruction. bP < 0.05 between spontaneous breathing and clinical CPAP or physiological CPAP or physiological CPAP+1 cmH2O. cP < 0.05 between clinical CPAP
and physiological CPAP. dP < 0.05 between spontaneous breathing and physiological CPAP or physiological CPAP+1 cmH2O.
Khirani et al. Critical Care 2013, 17:R167
http://ccforum.com/content/17/4/R167
Page 5 of 9
persisted during the clinical CPAP setting, as observed by
Lofaso et al. [19]. Indeed, these authors monitored Poes
and Pgas with airflow during nasal CPAP titration in 12
adult patients with OSA and observed that 6 patients pre-
sented expiratory abdominal activity during spontaneous
breathing. This expiratory abdominal activity persisted at
the CPAP level associated with the disappearance of
apnoea and disappeared only when a higher CPAP level
was reached [19]. The importance of this CPAP underti-
tration has recently been highlighted by Seo et al. [27].
These authors analysed the expiratory abdominal muscle
activity by means of surface electrodes in 81 patients with
OSA and periodic limb movements (PLMs) during CPAP
titration [27]. PLMs persisted in 72 patients while the
AASM-defined hypopnoea were eliminated [7]. These
subjects still showed a pattern of flow limitation and the
presence of cyclic alternative pattern during non-rapid eye
movement sleep. The disappearance of flow limitation
required a higher CPAP pressure and was associated with
the disappearance of PLMs. When comparing the CPAP
pressure necessary to eliminating AASM-defined hypop-
noea and the pressure required to eliminating PLMs, Seo
et al. found a mean difference of 1.47 ± 1.96 cmH2O.
Forty-four patients needed 2 cmH2O or greater CPAP
increase for the disappearance of flow limitation and PLM.
The clinical relevance of this high-target CPAP titration
seems important, as PLMs may be associated with evi-
dence of electroencephalographic changes of arousal and
with changes in the plethysmographic curve obtained
from a finger oximeter, which indicates sympathetic
stimulation [28]. Of note, the mean CPAP difference in
the present study was similar to that observed in adult
patients [27].
Our data underline the importance of expiratory
abdominal activity for optimal titration of CPAP in
infants, but an oesogastric pressure recording is not avail-
able in most centres. Surface electromyography of the
abdominal muscles is probably a promising tool and
worth being developed and validated for use in young
infants. In the meantime, it has to be noted that the clini-
cal CPAP level was associated with an improvement in
breathing pattern and respiratory effort, as well as excel-
lent clinical tolerance, with the majority of the patients
falling asleep. A first recommendation may thus be to set
CPAP at the level associated with the disappearance of
the stridor, SpO2 greater than 95%, the greatest decrease
in heart rate and fR, and the best comfort as assessed by
the infant falling asleep. As the mean difference between
the clinical CPAP level and the physiological CPAP level
was about 2 cmH2O, we recommend increasing the clini-
cal CPAP level by 1 to 2 cmH2O if this level remains
associated with the disappearance of the stridor, a SpO2
greater than 95%, the greatest decrease in heart rate and
fR and the best comfort as assessed by the infant’s
remaining or falling asleep.
Our study has several limitations. We were unable to
measure airflow and thus could not accurately report the
mechanical inspiratory time during spontaneous breath-
ing. Indeed, the increase in dead space following the
application of the nasal mask resulted in an increase in
respiratory effort and dyspnoea associated with a fall in
SpO2. Also, the occurrence of a continuous high airflow
Figure 1 Evolution of the oesophageal pressure (Poes) swing and the transdiaphragmatic pressure swing (Pdi) during spontaneous
breathing (SB), a clinical setting of noninvasive continuous positive airway pressure (CPAP Clin), a physiological setting of
noninvasive continuous positive airway pressure (CPAP Physio) and a physiological setting of noninvasive CPAP+1 cmH2O (CPAP
Physio + 1). BPD: bronchopulmonary dysplasia, UAO: upper airway obstruction.
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during CPAP precluded the measurement of the patient’s
own airflow. We did not monitor gas exchange in all the
infants during the study period. All the infants had severe
hypoxaemia and hypercapnia during sleep, which was
alleviated by nasal CPAP as previously reported by our
group in a comparable group of patients [3,5,6]. Despite
the fact that the infants fell asleep with the nasal CPAP,
we did not perform an overnight recording. This is a lim-
itation, as the most efficient pressure level may change
with the sleep stage. Different CPAP devices were used.
CPAP devices, as is true of other home ventilators, evolve
very rapidly. As CPAP is the most simple ventilator
mode, delivering only a constant positive pressure, the
choice of the device is mainly a question of ergonometry,
prescriber or patient preference. Indeed, we did not use
more recent CPAP modes, such as bilevel, auto-adjusted
and BiPAP Bi-Flex modes, which are not adapted for
infants as we have shown previously [5]. We acknowledge
that a small difference may be observed between the
CPAP level set on the device and the Paw measured by
the pressure transducer. In the present study, however, the
CPAP level reported was the Paw and not the level given
by the CPAP device. We did not perform a polysomnogra-
phy and are thus unable to confirm the association
between persistent respiratory effort and cortical arousal.
Conclusions
This study shows that a physiological setting of noninva-
sive CPAP, based on the recording of Poes and Pgas, may
be superior to a clinical setting based on clinical noninva-
sive parameters. Expiratory abdominal activity is worth
detecting, underlining the importance of the develop-
ment and validation of noninvasive, reliable and accurate
markers of abdominal activity for an optimal setting of
noninvasive CPAP in infants.
Key messages
• In routine care, CPAP level should be adjusted on the
disappearance of the stridor, retraction and/or dyspnoea, a
pulse oximetry greater than 95%, the greatest decrease in
heart and respiratory rates, and the best comfort as
assessed by the infant’s falling asleep.
Figure 2 Tracings of patient 9 showing the increases in oesophageal pressure (Poes) swing and transdiaphragmatic pressure (Pdi)
swing during spontaneous breathing, together with an approximately 10 cmH2O expiratory gastric pressure (Pgas) swing (arrow).
During a clinical setting of noninvasive continuous positive airway pressure (CPAP Clin) (that is, 6 cmH2O), a moderate decrease in the Poes and
Pdi swing is observed with the persistence of an approximately 10 cmH2O expiratory gastric pressure (Pgas) swing (arrow). During a
physiological setting of CPAP (CPAP Phys), note the important reduction in the Poes and Pdi swings and in the breathing rate with the
disappearance of the expiratory Pgas swing (arrow). When the physiological CPAP setting is increased by 1 cmH2O, a moderate increase in
expiratory Pgas swing is observed.
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• A setting of CPAP based on the recording of Poes
and Pgas may be superior to a clinical setting.
• Expiratory abdominal activity may be helpful for an
optimal titration of CPAP in infants.
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